These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19055481)

  • 21. In praise of toolmakers.
    Fenselau C
    J Proteome Res; 2009 May; 8(5):2135. PubMed ID: 19309079
    [No Abstract]   [Full Text] [Related]  

  • 22. Supervised feature selection in mass spectrometry-based proteomic profiling by blockwise boosting.
    Gertheiss J; Tutz G
    Bioinformatics; 2009 Apr; 25(8):1076-7. PubMed ID: 19233895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics for proteomics.
    Ahrens C; Jespersen H; Schandorff S
    Methods Biochem Anal; 2005; 45():249-72. PubMed ID: 19235299
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of labeling and label-free mass spectrometry-based proteomics approaches.
    Patel VJ; Thalassinos K; Slade SE; Connolly JB; Crombie A; Murrell JC; Scrivens JH
    J Proteome Res; 2009 Jul; 8(7):3752-9. PubMed ID: 19435289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
    Ahmed FE
    J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomics discovery of biomarkers.
    Massé R; Gibbs BF
    Methods Biochem Anal; 2005; 45():181-216. PubMed ID: 19235296
    [No Abstract]   [Full Text] [Related]  

  • 27. Strategy for surveying the proteome using affinity proteomics and mass spectrometry.
    Wingren C; James P; Borrebaeck CA
    Proteomics; 2009 Mar; 9(6):1511-7. PubMed ID: 19235165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shotgun mass spectrometry analysis of the human thalamus proteome.
    Martins-de-Souza D; Maccarrone G; Reckow S; Falkai P; Schmitt A; Turck CW
    J Sep Sci; 2009 Apr; 32(8):1231-6. PubMed ID: 19301323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass spectrometry-based proteomics and analyses of serum: a primer for the clinical investigator.
    Fusaro VA; Stone JH
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S3-14. PubMed ID: 14740422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass spectrometry as an emerging tool for systems biology.
    Yates JR
    Biotechniques; 2004 Jun; 36(6):917-9. PubMed ID: 15211739
    [No Abstract]   [Full Text] [Related]  

  • 31. Proteomics: the basic overview.
    Figeys D
    Methods Biochem Anal; 2005; 45():1-62. PubMed ID: 19235290
    [No Abstract]   [Full Text] [Related]  

  • 32. Guidelines for reporting the use of mass spectrometry in proteomics.
    Taylor CF; Binz PA; Aebersold R; Affolter M; Barkovich R; Deutsch EW; Horn DM; Hühmer A; Kussmann M; Lilley K; Macht M; Mann M; Müller D; Neubert TA; Nickson J; Patterson SD; Raso R; Resing K; Seymour SL; Tsugita A; Xenarios I; Zeng R; Julian RK
    Nat Biotechnol; 2008 Aug; 26(8):860-1. PubMed ID: 18688232
    [No Abstract]   [Full Text] [Related]  

  • 33. Mass spectrometry-based proteomics: principles, perspectives, and challenges.
    Wiśniewski JR
    Arch Pathol Lab Med; 2008 Oct; 132(10):1566-9. PubMed ID: 18834211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives for imaging mass spectrometry in the proteomics landscape.
    MacAleese L; Stauber J; Heeren RM
    Proteomics; 2009 Feb; 9(4):819-34. PubMed ID: 19212956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New horizons in biological research developed by next-generation proteomics: say good-bye to Western blotting].
    Nakatsumi H; Matsumoto M; Nakayama K
    Seikagaku; 2012 Jan; 84(1):53-7. PubMed ID: 22416474
    [No Abstract]   [Full Text] [Related]  

  • 36. In-Gel 18O labeling for improved identification of proteins from 2-DE Gel spots in comparative proteomic experiments.
    Broedel O; Krause E; Stephanowitz H; Schuemann M; Eravci M; Weist S; Brunkau C; Wittke J; Eravci S; Baumgartner A
    J Proteome Res; 2009 Jul; 8(7):3771-7. PubMed ID: 19425618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparing multiple-reaction monitoring for quantitative clinical proteomics.
    Kim K; Kim Y
    Expert Rev Proteomics; 2009 Jun; 6(3):225-9. PubMed ID: 19489693
    [No Abstract]   [Full Text] [Related]  

  • 38. Microfluidic chips for mass spectrometry-based proteomics.
    Lee J; Soper SA; Murray KK
    J Mass Spectrom; 2009 May; 44(5):579-93. PubMed ID: 19373851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Power and limitations of electrophoretic separations in proteomics strategies.
    Rabilloud T; Vaezzadeh AR; Potier N; Lelong C; Leize-Wagner E; Chevallet M
    Mass Spectrom Rev; 2009; 28(5):816-43. PubMed ID: 19072760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical tools for temporally and spatially resolved mass spectrometry-based proteomics.
    Yuet KP; Tirrell DA
    Ann Biomed Eng; 2014 Feb; 42(2):299-311. PubMed ID: 23943069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.